Lisa A. Jackson, MD, MPH
Senior Investigator
206-442-5216
jackson.l@ghc.org
Recent publications
Curriculum vitae (CV)
Research interests and experience
- Immunization & infectious diseases: vaccine safety; influenza vaccine effectiveness in the elderly; methodologic issues in vaccine effectiveness evaluations; pneumococcal polysaccharide vaccine effectiveness; pneumococcal conjugate vaccine immunogenicity in the elderly; epidemiology of E. coli bacteremia; epidemiology of community-acquired pneumonia
Lisa Jackson is an internist and infectious disease epidemiologist with research interests in evaluations of vaccine safety and effectiveness and the epidemiology of vaccine preventable diseases.
Recent publications
Jackson LA, Gurtman A, van Cleeff M, Frenck RW, Treanor J, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine. 2013 May 17. pii: S0264-410X(13)00586-0. doi: 10.1016/j.vaccine.2013.04.084. [Epub ahead of print]. PubMed
Jackson LA, Gurtman A, Rice K, Pauksens K, Greenberg RN, Jones TR, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2013 May 17. pii: S0264-410X(13)00588-4. doi: 10.1016/j.vaccine.2013.05.010. [Epub ahead of print]. PubMed
Jackson LA, Gurtman A, Van Cleeff M, Jansen KU, Jayawardene D, Devlin C, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine. 2013 May 17. pii: S0264-410X(13)00587-2. doi: 10.1016/j.vaccine.2013.04.085. [Epub ahead of print]. PubMed
Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Cost-effectiveness of adult pneumococcal vaccination: Response to Grabenstein et al. Vaccine. 2013 Apr 19;31(17):2109. doi: 10.1016/j.vaccine.2013.01.008. Epub 2013 Jan 11. PubMed
Jackson L, Jackson ML, Phillips, H, Benoit J. Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013 MMWR Morb Mortal Wkly Rep. February 22, 2013 / 62(07);119-123.
Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E. Vaccination site and risk of local reactions in children 1 through 6 years of age. Pediatrics. 2013 Feb;131(2):283-9. doi: 10.1542/peds.2012-2617. Epub 2013 Jan 14. PubMed
Jackson LA, Jackson ML, Phillips H, Benoit J. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2013 MMWR Morb Mortal Wkly Rep. 2013 Jan 18 / 62(02);32-5.
Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, Destefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, Belongia EA; for the Vaccine Safety Datalink. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013 Jan;121(1):159-65. PubMed
Nelson JC, Yu O, Dominguez C, Cook AJ, Peterson D, Greene SK, Yih K, Daley MF, Jacobsen SJ, Klein NP, Weintraub E, Jackson LA. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15;177(2):131-41. doi: 10.1093/aje/kws317. Epub 2013 Jan 4.
Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2012 Nov 28 [Epub ahead of print]. PubMed
To view more publications, please see Dr. Jackson's CV.